salmon calcitonin (Calcimar)

10/01/1992 - "Accordingly, we report a case of a hypogonadal male with histologically proven low bone turnover osteoporosis and a progressive vertebral fracture syndrome, who responded favorably to ADFR treatment with the use of salmon calcitonin and inorganic phosphate. "
10/01/1998 - "Prospective studies have shown that salcatonin is effective in the treatment of established osteoporosis, reducing significantly the relative risk of new vertebral fractures. "
01/01/1997 - "The experimental and clinical effectiveness of nasal salmon calcitonin (SCT) for treatment of osteoporosis in humans has been well established, but none is known yet about the pharmacokinetic property in relation to therapeutic efficacy, especially when used in a therapeutic dose range. "
03/01/1995 - "These findings suggest that salmon calcitonin is effective in the treatment of osteoporosis and show that it acts on cortical and trabecular bone."
11/01/2014 - "It is effective and safe to use salmon calcitonin in the treatment of elderly women with type 2 diabetes complicated with osteoporosis. "

01/01/1992 - "In addition, salmon calcitonin has a potent analgesic effect, thereby causing a reduction in bone pain and improvement in functional capacity. "
01/01/1991 - "Intravenous salmon-calcitonin infusions administered at our pain clinic led to almost complete remission of pain. "
03/01/2006 - "The aim of the study was to assess the efficacy of salmon calcitonin, which was suggested as effective in the treatment of complex regional pain syndrome type 1 (CRPS 1). "
03/01/2006 - "Efficacy of salmon calcitonin in complex regional pain syndrome (type 1) in addition to physical therapy."
10/01/1997 - "Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. "

10/01/1973 - "Salmon calcitonin is effective in combating hypercalcemia."
01/01/1990 - "Salmon calcitonin is therefore effective and safe in the management of acute hypercalcemia."
04/01/1987 - "Thus, salmon calcitonin administered by the rectal route appears to be an easy, safe, and effective treatment of moderate hypercalcemia without apparent side effects."
02/01/2014 - "Salmon calcitonin (sCT) is approved for the short-term treatment of Paget's disease and hypercalcemia. "
05/01/1997 - "ALLN [100 mg/kg, intraperitoneally (i.p.)] inhibited hypercalcemia by 62.8% acutely (p < 0.001), compared to 94.9% (p < 0.001) inhibition by salmon calcitonin (sCT) (10 IU/kg, subcutaneously). "

08/01/1994 - "The aim of this paper was to evaluate the long-term (5 years) efficacy of nasal salmon calcitonin in prevention of trabecular postmenopausal bone loss, which was a follow-up of a previously published study (3 years); a randomized, controlled group comparison. "
04/01/1984 - "Results are presented from a 2-year controlled study evaluating the efficacy of 100 units synthetic salmon calcitonin/d in the treatment of postmenopausal osteoporosis. "
07/01/1989 - "[Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis]."
12/01/2005 - "We aimed to compare and evaluate the efficacies of a continuous regimen of intranasal salmon calcitonin (SCT) and two cyclic regimens (different cyclic regimens from previous studies) based on alternating 15 days or on 10 days consecutively per month for 1 year in the treatment of postmenopausal osteoporosis. "
12/01/1994 - "and intramuscular (i.m.) salmon calcitonin (sCT) and of placebo in women affected by painful post-menopausal osteoporosis, in a double-blind, double-placebo trial. "

01/01/1989 - "[Results in Miacalcic therapy in the analgesic treatment of patients with bone metastases]."
01/01/1986 - "The analgesic effect of salmon calcitonin was tested by a double-blind clinical randomized controlled trial in 40 female patients with painful osteolytic metastases. "
01/01/1986 - "Salmon calcitonin in the treatment of bone metastases."
10/01/2006 - "We undertook a prospective, nonrandomized study with the objective to evaluate the efficacy of salmon calcitonin (sCT) in controlling pain secondary to bone metastases. "
01/01/1994 - "A pilot study to assess the efficacy of salmon calcitonin in the relief of neuropathic pain caused by extraskeletal metastases."